Skip to main content
OpenTrials
Completed

NCT Number: NCT06952361

Evaluation of Alternative Transfusion Triggers in Hemodynamically Stable, Non-Ventilated Cancer Patients

This is a prospective, single-center observational study conducted at the Kazakh Institute of Oncology and Radiology. The study included 107 clinically stable adult patients with cancer who required red blood cell transfusion based on a restrictive hemoglobin threshold. The aim of the study was to evaluate alternative physiological indicators of transfusion need and effectiveness. Measurements included oxygen extraction ratio (O₂ER), central venous oxygen saturation (ScvO₂), partial pressure of oxygen in central venous blood (PvO₂), arterio-venous oxygen difference (A-VO₂diff), lactate, and veno-arterial carbon dioxide difference (ΔCO₂). These parameters were assessed before and one hour after transfusion. For data analysis, patients were stratified into two groups based on their baseline O₂ER (≤35.4% and >35.4%) to evaluate whether higher O₂ER is associated with more pronounced physiological response to transfusion.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Kazakh Institute of Oncology and Radiology

Almaty, 050000, Kazakhstan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult cancer patients (age 18 years or older)
  • Hemodynamically stable
  • Not requiring any form of respiratory support
  • Presence of a central venous catheter inserted into the superior vena cava

Exclusion criteria

  • Hemodynamic instability requiring inotropic or vasopressor support
  • Active bleeding
  • Shock of any etiology
  • Patient refusal to participate in the study
  • Hematological malignancies
  • Age under 18 years
  • Pregnancy

Treatment and study plan

Red blood cell transfusion

Procedure

Standard red blood cell transfusion performed as part of routine clinical care. All participants received one or more units of RBCs based on a restrictive hemoglobin threshold. The transfusion protocol was not altered for the purpose of the study.

Primary outcomes

  1. Change in Oxygen Extraction Ratio (O₂ER)

    Time frame: Baseline and 1 hour post-transfusion

    Difference in oxygen extraction ratio measured before and one hour after red blood cell transfusion

Secondary outcomes

  1. Change in Partial Pressure of Oxygen in Central Venous Blood (PvO₂)

    Time frame: Baseline and 1 hour post-transfusion

    Difference in PvO₂ measured before and one hour after transfusion

  2. Change in Central Venous Oxygen Saturation (ScvO₂)

    Time frame: Baseline and 1 hour post-transfusion

    Difference in ScvO₂ measured before and one hour after transfusion

  3. Change in Lactate Concentration

    Time frame: Baseline and 1 hour post-transfusion

    Difference in serum lactate measured before and one hour after transfusion

  4. Change in Arterio-Venous Oxygen Difference (A-VO₂diff)

    Time frame: Baseline and 1 hour post-transfusion

    Difference in arteriovenous oxygen difference measured before and one hour after transfusion

  5. Change in Veno-Arterial Carbon Dioxide Difference (ΔCO₂)

    Time frame: Baseline and 1 hour post-transfusion

    Difference in ΔCO₂ measured before and one hour after transfusion

Sponsors and collaborators

Lead sponsor

Ardak Arynov

Other

Registry information

Official study title

Evaluation of Alternative Transfusion Triggers in Hemodynamically Stable, Non-Ventilated Cancer Patients: A Prospective Observational Study

Important dates

Study start
2019
Primary completion
2021
Study completion
2021
First posted
Apr 30, 2025
Registry last updated
May 21, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.